Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""ANTICOAGULANTS"" wg kryterium: Temat


Tytuł :
Direct-acting oral anti-coagulants in dental practice: A Retrospective Observational Study (Part 1).
Autorzy :
Kim T; Tufts University School of Dental Medicine, Boston, Massachusetts, USA.
Finkelman M; Department of Public Health and Community Service, Tufts University School of Dental Medicine, Boston, Massachusetts, USA.
Desai B; Private Practice, Milwaukee, Wisconsin, USA.
Farag A; Department of Oral Diagnostic Clinical Sciences, Faculty of Dentistry, King AbdulAziz University, Jeddah, Saudi Arabia.; Department of Diagnostic Sciences, Oral Medicine Division Tufts University School of Dental Medicine, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Oral diseases [Oral Dis] 2021 May; Vol. 27 (4), pp. 1052-1058. Date of Electronic Publication: 2020 Sep 13.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Anticoagulants*/adverse effects
Postoperative Hemorrhage*/chemically induced
Postoperative Hemorrhage*/epidemiology
Postoperative Hemorrhage*/prevention & control
Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The Potency of Seaweed Sulfated Polysaccharides for the Correction of Hemostasis Disorders in COVID-19.
Autorzy :
Kuznetsova TA; G.P. Somov Institute of Epidemiology and Microbiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 690087 Vladivostok, Russia.
Andryukov BG; G.P. Somov Institute of Epidemiology and Microbiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 690087 Vladivostok, Russia.; School of Biomedicine, Far Eastern Federal University (FEFU), 690091 Vladivostok, Russia.
Makarenkova ID; G.P. Somov Institute of Epidemiology and Microbiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 690087 Vladivostok, Russia.
Zaporozhets TS; G.P. Somov Institute of Epidemiology and Microbiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 690087 Vladivostok, Russia.
Besednova NN; G.P. Somov Institute of Epidemiology and Microbiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 690087 Vladivostok, Russia.
Fedyanina LN; School of Biomedicine, Far Eastern Federal University (FEFU), 690091 Vladivostok, Russia.
Kryzhanovsky SP; Medical Association of the Far Eastern Branch of the Russian Academy of Sciences, 690022 Vladivostok, Russia.
Shchelkanov MY; G.P. Somov Institute of Epidemiology and Microbiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 690087 Vladivostok, Russia.; School of Biomedicine, Far Eastern Federal University (FEFU), 690091 Vladivostok, Russia.; Federal Scientific Center of the Eastern Asia Terrestrial Biodiversity, Far Eastern Branch of Russian Academy of Sciences, 690091 Vladivostok, Russia.; National Scientific Center of Marine Biology, Far Eastern Branch of Russian Academy of Sciences, 690091 Vladivostok, Russia.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2021 Apr 29; Vol. 26 (9). Date of Electronic Publication: 2021 Apr 29.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Seaweed*/chemistry
Anticoagulants/*pharmacology
COVID-19/*complications
Hemostasis/*drug effects
Polysaccharides/*pharmacology
Sulfates/*pharmacology
Thrombosis/*complications
Animals ; Anticoagulants/chemistry ; Anticoagulants/pharmacokinetics ; Anticoagulants/therapeutic use ; COVID-19/blood ; COVID-19/drug therapy ; Drug Discovery ; Humans ; Polysaccharides/chemistry ; Polysaccharides/pharmacokinetics ; Polysaccharides/therapeutic use ; Sulfates/chemistry ; Sulfates/pharmacokinetics ; Sulfates/therapeutic use ; Thrombosis/blood ; Thrombosis/drug therapy
Czasopismo naukowe
Tytuł :
Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population.
Autorzy :
Gurbel PA; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, 21215, USA. .
Bliden KP; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, 21215, USA.
Rout A; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, 21215, USA.
Rapista N; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, 21215, USA.
Walia N; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, 21215, USA.
Chaudhary R; Division of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Ens G; Inflammatory Markers Laboratory, Wichita, KS, USA.
Traianova M; CEDEX Laboratory, Nashua, NH, USA.
Barnes JS; Critical Care Medicine, Sinai Hospital and Northwest Hospital, Lifebridge Health, Baltimore, MD, USA.
Tantry US; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, 21215, USA.
Pokaż więcej
Źródło :
Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2021 May; Vol. 51 (4), pp. 902-904. Date of Electronic Publication: 2021 Apr 07.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Anticoagulants*/administration & dosage
Anticoagulants*/pharmacokinetics
Aspirin*/administration & dosage
Aspirin*/pharmacokinetics
COVID-19*/blood
COVID-19*/diagnosis
COVID-19*/drug therapy
COVID-19*/physiopathology
Heparin*/administration & dosage
Heparin*/pharmacokinetics
Biomarkers, Pharmacological/*blood
Point-of-Care Testing/*statistics & numerical data
Thrombelastography/*methods
African Americans/statistics & numerical data ; Biological Availability ; Female ; Hemostasis/drug effects ; Hemostasis/physiology ; Humans ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/pharmacokinetics ; Platelet Function Tests/methods ; Platelet Function Tests/statistics & numerical data ; SARS-CoV-2 ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Risk of Stroke Outcomes in Atrial Fibrillation Patients Treated with Rivaroxaban and Warfarin.
Autorzy :
Milentijevic D; Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, United States. Electronic address: .
Lin JH; Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, United States.
Connolly N; Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, United States.
Chen YW; Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, United States.
Kogan E; Janssen Research & Development, LLC, Raritan, NJ, United States.
Shrivastava S; Mu Sigma Business Solutions Pvt. Ltd., Bengaluru, India.
Sjoeland E; Janssen Research & Development, LLC, Raritan, NJ, United States.
Alberts MJ; Hartford HealthCare, Hartford, CT, United States.
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 May; Vol. 30 (5), pp. 105715. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Atrial Fibrillation/*drug therapy
Factor Xa Inhibitors/*therapeutic use
Rivaroxaban/*therapeutic use
Stroke/*prevention & control
Warfarin/*therapeutic use
Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/epidemiology ; Databases, Factual ; Factor Xa Inhibitors/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Rivaroxaban/adverse effects ; Severity of Illness Index ; Stroke/diagnosis ; Stroke/epidemiology ; Time Factors ; Treatment Outcome ; United States/epidemiology ; Warfarin/adverse effects
Czasopismo naukowe
Tytuł :
Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
Autorzy :
Desai A; Department of Neurology, Section of Vascular and Neurological Critical Care, Baylor College of Medicine.
Escamilla-Ocanas C; Department of Neurology, Section of Vascular and Neurological Critical Care, Baylor College of Medicine.
Dilip D; Department of Neurology, Section of Vascular and Neurological Critical Care, Baylor College of Medicine; David Geffen School of Medicine, Comprehensive Stroke Center, Department of Neurology, University of California, Los Angeles, Los Angeles.
Saber H; David Geffen School of Medicine, Comprehensive Stroke Center, Department of Neurology, University of California, Los Angeles, Los Angeles.
Damani R; Department of Neurology, Section of Vascular and Neurological Critical Care, Baylor College of Medicine. Electronic address: .
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Apr; Vol. 30 (4), pp. 105654. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Dual Anti-Platelet Therapy*/adverse effects
Dual Anti-Platelet Therapy*/mortality
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/instrumentation
Percutaneous Coronary Intervention*/mortality
Anticoagulants/*therapeutic use
Atrial Fibrillation/*drug therapy
Coronary Artery Disease/*therapy
Ischemic Stroke/*prevention & control
Platelet Aggregation Inhibitors/*therapeutic use
Aged ; Anticoagulants/adverse effects ; Atrial Fibrillation/complications ; Atrial Fibrillation/mortality ; Cerebral Hemorrhage/chemically induced ; Coronary Artery Disease/mortality ; Female ; Humans ; Ischemic Stroke/etiology ; Ischemic Stroke/mortality ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Stents ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Double-edged sword effect of anticoagulant in COVID-19 infection.
Autorzy :
Ohn MH; Cardiology Department, Lewisham Hospital NHS Trust, London, UK.
Ng JR; Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia.
Ohn KM; Surgical Department, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia .
Luen NP; Emergency Department, Miri Hospital, Miri, Sarawak, Malaysia.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Mar 22; Vol. 14 (3). Date of Electronic Publication: 2021 Mar 22.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Retroperitoneal Space*
Anticoagulants/*adverse effects
COVID-19/*drug therapy
Hemorrhage/*chemically induced
Heparin/*adverse effects
Anticoagulants/administration & dosage ; Anticoagulants/therapeutic use ; COVID-19/complications ; COVID-19/diagnostic imaging ; Drug Administration Schedule ; Fatal Outcome ; Female ; Heparin/administration & dosage ; Heparin/therapeutic use ; Humans ; Middle Aged ; Radiography ; SARS-CoV-2 ; Tomography, X-Ray Computed ; Venous Thromboembolism/prevention & control
Czasopismo naukowe
Tytuł :
A regular fucan sulfate from Stichopus herrmanni and its peroxide depolymerization: Structure and anticoagulant activity.
Autorzy :
Li X; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China; Chuxiong Medical College, Chuxiong, 675005, China.
Li S; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
Liu J; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.
Lin L; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
Sun H; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China.
Yang W; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China.
Cai Y; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
Gao N; School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan, 430074, China.
Zhou L; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
Qin H; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China. Electronic address: .
Yin R; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China; School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan, 430074, China. Electronic address: .
Zhao J; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China; School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan, 430074, China. Electronic address: .
Pokaż więcej
Źródło :
Carbohydrate polymers [Carbohydr Polym] 2021 Mar 15; Vol. 256, pp. 117513. Date of Electronic Publication: 2020 Dec 15.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*chemistry
Blood Coagulation/*drug effects
Peroxides/*chemistry
Polysaccharides/*chemistry
Stichopus/*chemistry
Animals ; Anticoagulants/isolation & purification ; Anticoagulants/pharmacology ; Aquatic Organisms ; Blood Coagulation Tests ; Carbohydrate Sequence ; Heparin Cofactor II/pharmacology ; Humans ; Hydrolysis ; Molecular Weight ; Polysaccharides/isolation & purification ; Polysaccharides/pharmacology ; Stichopus/physiology ; Structure-Activity Relationship ; Thrombin/antagonists & inhibitors ; Thrombin/metabolism
Czasopismo naukowe
Tytuł :
A retrospective analysis of dental implantation under anticoagulant treatment.
Autorzy :
Manor Y; Department of Oral and Maxillofacial Surgery, School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel. .
Peleg O; Department of Oral and Maxillofacial Surgery, Sorasky Medical Center, Tel Aviv, Israel.
Mijiritsky E; Department of Oral and Maxillofacial Surgery, Sorasky Medical Center, Tel Aviv, Israel.
Manor A; Economical Unit, Edith Wolfson Medical Center, Holon, Israel.
Reiter S; Department of Oral Medicine, School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel.
Pokaż więcej
Źródło :
Clinical oral investigations [Clin Oral Investig] 2021 Mar; Vol. 25 (3), pp. 1001-1009. Date of Electronic Publication: 2020 Jun 06.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants*/therapeutic use
Postoperative Hemorrhage*/prevention & control
Administration, Oral ; Aged ; Dental Implantation ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
Autorzy :
Mowla A; Division of Endovascular Neurosurgery, Department of Neurological Surgery, Keck School of Medicine, University of Southern California (USC), 1200 North State St., Suite 3300, Los Angeles, CA 90033, United States. Electronic address: .
Memon A; Department of Neurology, Emory University, Atlanta, GA, United States.
Razavi SM; Heart and Rhythm Clinic, San Jose, CA, United States.
Lail NS; Department of Neurology, University at Buffalo, State University of New York, Buffalo, NY, United States.
Vaughn CB; Department of Neurology, University at Buffalo, State University of New York, Buffalo, NY, United States.
Mohammadi P; California Institute of Neuroscience, Thousand Oaks, CA, United States.
Sawyer RN; Department of Neurology, University at Buffalo, State University of New York, Buffalo, NY, United States.
Shirani P; Departments of Neurology and Neurosurgery, University of Cincinnati Medical Center, Cincinnati, OH, United States.
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 May; Vol. 30 (5), pp. 105678. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Monitoring*
International Normalized Ratio*
Thrombolytic Therapy*/adverse effects
Thrombolytic Therapy*/mortality
Anticoagulants/*therapeutic use
Fibrinolytic Agents/*administration & dosage
Ischemic Stroke/*drug therapy
Tissue Plasminogen Activator/*administration & dosage
Warfarin/*therapeutic use
Administration, Intravenous ; Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; Cerebral Hemorrhage/chemically induced ; Clinical Decision-Making ; Databases, Factual ; Female ; Fibrinolytic Agents/adverse effects ; Humans ; Ischemic Stroke/blood ; Ischemic Stroke/diagnosis ; Ischemic Stroke/mortality ; Male ; New York ; Predictive Value of Tests ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Tissue Plasminogen Activator/adverse effects ; Treatment Outcome ; Warfarin/adverse effects
Czasopismo naukowe
Tytuł :
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
Autorzy :
Sadeghipour P; Cardiovascular Intervention Research Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran.; Clinical Trial Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Talasaz AH; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Rashidi F; Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Sharif-Kashani B; Tobacoo Prevention and control Research center, National Research institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Lung Transplantation Research Center, Department of Cardiology, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Beigmohammadi MT; Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Farrokhpour M; Firouzgar hospital, Department of internal medicine, Iran University of Medical Sciences, Tehran, Iran.
Sezavar SH; Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology & Metabolism, Iran University of Medical Sciences, Tehran, Iran.
Payandemehr P; Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Dabbagh A; Department of Anesthesiology, School of Medicine Anesthesiology Research Center Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Moghadam KG; School of Medicine, Department of Internal Medicine, Shariati Hospital, Tehran, Iran.
Jamalkhani S; Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
Khalili H; Department of Pharmacotherapy, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Yadollahzadeh M; Firouzgar hospital, Department of internal medicine, Iran University of Medical Sciences, Tehran, Iran.
Riahi T; Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Rezaeifar P; Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Tahamtan O; Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Matin S; Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abedini A; Chronic Respiratory Disease Research Center, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Lookzadeh S; Chronic Respiratory Disease Research Center, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Rahmani H; Department of Pharmacotherapy, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Zoghi E; School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadi K; School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Sadeghipour P; Firouzgar hospital, Department of internal medicine, Iran University of Medical Sciences, Tehran, Iran.
Abri H; Firouzgar hospital, Department of internal medicine, Iran University of Medical Sciences, Tehran, Iran.
Tabrizi S; Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Mousavian SM; Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Shahmirzaei S; Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Bakhshandeh H; Clinical Trial Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran.; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
Amin A; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
Rafiee F; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
Baghizadeh E; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
Mohebbi B; Cardiovascular Intervention Research Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Parhizgar SE; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
Aliannejad R; School of Medicine, Department of Pulmonary and Critical Care, Shariati Hospital, Tehran, Iran.; Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Eslami V; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Kashefizadeh A; Shahid Dr Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Kakavand H; School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Hosseini SH; School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Shafaghi S; Lung Transplantation Research Center, Department of Cardiology, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ghazi SF; Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Najafi A; Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Jimenez D; Respiratory Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain.; Medicine Department, Universidad de Alcalá (IRYCIS), Madrid, Spain.; CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Gupta A; Cardiovascular Research Foundation (CRF), New York, New York.; Division of Cardiology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York.; Yale/YNHH Center for Outcomes Research & Evaluation, New Haven, Connecticut.
Madhavan MV; Cardiovascular Research Foundation (CRF), New York, New York.; Division of Cardiology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York.
Sethi SS; Cardiovascular Research Foundation (CRF), New York, New York.; Division of Cardiology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York.
Parikh SA; Cardiovascular Research Foundation (CRF), New York, New York.; Division of Cardiology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York.
Monreal M; Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Universidad Católica de Murcia, Murcia, Spain.
Hadavand N; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
Hajighasemi A; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Maleki M; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
Sadeghian S; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Piazza G; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Kirtane AJ; Cardiovascular Research Foundation (CRF), New York, New York.; Division of Cardiology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York.
Van Tassell BW; School of Pharmacy, Department of Pharmacotherapy and Outcome Science, Virginia Commonwealth University, Richmond, Virginia.; School of Pharmacy, Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Dobesh PP; College of Pharmacy, University of Nebraska Medical Center, Omaha.
Stone GW; Cardiovascular Research Foundation (CRF), New York, New York.; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.; Aalborg University, Aalborg, Denmark.
Krumholz HM; Yale/YNHH Center for Outcomes Research & Evaluation, New Haven, Connecticut.; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.; Department of Health Policy and Administration, Yale School of Public Health, New Haven, Connecticut.
Goldhaber SZ; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Bikdeli B; Cardiovascular Research Foundation (CRF), New York, New York.; Yale/YNHH Center for Outcomes Research & Evaluation, New Haven, Connecticut.; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Corporate Authors :
INSPIRATION Investigators
Źródło :
JAMA [JAMA] 2021 Apr 27; Vol. 325 (16), pp. 1620-1630.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Extracorporeal Membrane Oxygenation*
Anticoagulants/*administration & dosage
COVID-19/*complications
Enoxaparin/*administration & dosage
Oxygen Inhalation Therapy/*methods
Thrombosis/*prevention & control
Aged ; Anticoagulants/adverse effects ; COVID-19/mortality ; Drug Administration Schedule ; Enoxaparin/adverse effects ; Female ; Hemorrhage/chemically induced ; Hospitalization ; Humans ; Intensive Care Units ; Iran ; Length of Stay/statistics & numerical data ; Male ; Middle Aged ; Odds Ratio ; Outcome Assessment, Health Care ; Pulmonary Embolism/epidemiology ; Thrombocytopenia/chemically induced ; Thrombosis/etiology ; Thrombosis/mortality ; Treatment Outcome ; Venous Thrombosis/epidemiology ; Venous Thrombosis/mortality
Czasopismo naukowe
Tytuł :
The relationship between DOAC levels and clinical outcomes: The measures tell the tale-Response from original authors Lijfering et al.
Autorzy :
Toorop MMA; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Scheres LJJ; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Lijfering WM; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Apr; Vol. 19 (4), pp. 1136-1138.
Typ publikacji :
Letter; Comment
MeSH Terms :
Anticoagulants*
Atrial Fibrillation*
Humans
Opinia redakcyjna
Tytuł :
Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate.
Autorzy :
Osawa I; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Okamoto K; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. .
Ikeda M; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.; Department of Infection Control and Prevention, The University of Tokyo Hospital, Tokyo, Japan.
Otani A; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Wakimoto Y; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Yamashita M; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Shinohara T; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Kanno Y; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Jubishi D; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Kurano M; Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
Harada S; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.; Department of Infection Control and Prevention, The University of Tokyo Hospital, Tokyo, Japan.
Okugawa S; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Yatomi Y; Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
Moriya K; Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.; Department of Infection Control and Prevention, The University of Tokyo Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2021 Apr; Vol. 51 (3), pp. 649-656. Date of Electronic Publication: 2020 Sep 12.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Benzamidines/*therapeutic use
COVID-19/*drug therapy
Fibrin Fibrinogen Degradation Products/*metabolism
Fibrinogen/*metabolism
Guanidines/*therapeutic use
Aged ; Anticoagulants/pharmacology ; Benzamidines/pharmacology ; COVID-19/blood ; COVID-19/classification ; Female ; Fibrinogen/drug effects ; Guanidines/pharmacology ; Humans ; Male ; Middle Aged ; Retrospective Studies
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
The Proportion of Preventable Thrombectomy Procedures with Improved Atrial Fibrillation Stroke Prevention.
Autorzy :
Sur NB; University of Miami Miller School of Medicine, Department of Neurology, 1120 NW 14th Street, Miami, FL 33136, USA. Electronic address: .
Saini V; University of Miami Miller School of Medicine, Department of Neurology, 1120 NW 14th Street, Miami, FL 33136, USA.
Torres LF; University of Texas at Houston McGovern Medical School, Houston, TX, USA.
Atchaneeyasakul K; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Malik AM; University of Miami Miller School of Medicine, Department of Neurology, 1120 NW 14th Street, Miami, FL 33136, USA.
Yavagal DR; University of Miami Miller School of Medicine, Department of Neurology, 1120 NW 14th Street, Miami, FL 33136, USA.
Chaturvedi S; University of Maryland Department of Neurology, Baltimore, MD, USA.
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Apr; Vol. 30 (4), pp. 105599. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Thrombectomy*/adverse effects
Thrombectomy*/mortality
Anticoagulants/*administration & dosage
Atrial Fibrillation/*drug therapy
Stroke/*prevention & control
Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; Atrial Fibrillation/complications ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/mortality ; Female ; Hospital Mortality ; Humans ; Intracranial Hemorrhages/chemically induced ; Male ; Middle Aged ; Primary Prevention ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Secondary Prevention ; Stroke/diagnosis ; Stroke/etiology ; Stroke/mortality ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Thromboprophylaxis following cesarean in women with class III obesity: a proposed alternative dosing regimen.
Autorzy :
Fischer RL; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Cooper Medical School of Rowan University, Cooper University Hospital, 1 Cooper Plaza, Room 623, Dorrance Bldg., Camden, NJ 08103. Electronic address: .
Mele M; Division of Obstetrical Anesthesia, Department of Anesthesiology, Cooper Medical School of Rowan University, Cooper University Hospital, Camden, NJ.
Pokaż więcej
Źródło :
American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2021 Apr; Vol. 224 (4), pp. 415-416. Date of Electronic Publication: 2020 Dec 08.
Typ publikacji :
Letter; Comment
MeSH Terms :
Anticoagulants*/therapeutic use
Venous Thromboembolism*/prevention & control
Cesarean Section ; Female ; Humans ; Obesity/complications ; Perinatology ; Pregnancy
Opinia redakcyjna
Tytuł :
Fucoidan mitigated diabetic nephropathy through the downregulation of PKC and modulation of NF-κB signaling pathway: in vitro and in vivo investigations.
Autorzy :
Xu J; College of Pharmacy, Linyi University, Linyi, Shandong, China.
Wang Y; College of Pharmacy, Linyi University, Linyi, Shandong, China.
Wang Z; College of Pharmacy, Linyi University, Linyi, Shandong, China.; National Resources Center of Chinese Material Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Guo L; National Resources Center of Chinese Material Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Li X; College of Pharmacy, Linyi University, Linyi, Shandong, China.
Pokaż więcej
Źródło :
Phytotherapy research : PTR [Phytother Res] 2021 Apr; Vol. 35 (4), pp. 2133-2144. Date of Electronic Publication: 2020 Dec 02.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Diabetes Mellitus, Experimental/*complications
Diabetic Nephropathies/*drug therapy
NF-kappa B/*metabolism
Peptide Fragments/*metabolism
Polysaccharides/*therapeutic use
Protein Kinase C/*metabolism
Animals ; Anticoagulants/pharmacology ; Diabetes Mellitus, Experimental/drug therapy ; Diabetic Nephropathies/pathology ; Down-Regulation ; Male ; Polysaccharides/pharmacology ; Rats ; Rats, Sprague-Dawley ; Signal Transduction
Czasopismo naukowe
Tytuł :
Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19.
Autorzy :
Seelhammer TG; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN. Electronic address: .
Rowse P; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN.
Yalamuri S; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.
Pokaż więcej
Źródło :
Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2021 Apr; Vol. 35 (4), pp. 1149-1153. Date of Electronic Publication: 2020 Jun 25.
Typ publikacji :
Case Reports
MeSH Terms :
Anticoagulants/*administration & dosage
Antithrombins/*administration & dosage
COVID-19/*diagnosis
COVID-19/*therapy
Extracorporeal Membrane Oxygenation/*adverse effects
Hirudins/*administration & dosage
Peptide Fragments/*administration & dosage
Thrombosis/*prevention & control
Aged ; Anticoagulants/therapeutic use ; Antithrombins/therapeutic use ; COVID-19/complications ; COVID-19 Nucleic Acid Testing ; Female ; Humans ; Peptide Fragments/therapeutic use ; Polymerase Chain Reaction ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/therapeutic use ; Respiratory Insufficiency/etiology ; Respiratory Insufficiency/therapy ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; Treatment Outcome
Raport
Tytuł :
Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status.
Autorzy :
Li W; Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Xu Z; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Xiang H; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Zhang C; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Guo Y; Medical School of Chinese PLA, Department of Cardiology, Chinese PLA General Hospital, Beijing 100853, China.; Liverpool Centre for Cardiovascular Sciences, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool L69 3BX, United Kingdom.
Xiong J; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Pokaż więcej
Źródło :
Aging [Aging (Albany NY)] 2021 Mar 26; Vol. 13 (7), pp. 9225-9242. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticoagulants/*therapeutic use
COVID-19/*complications
Thromboembolism/*drug therapy
Thromboembolism/*etiology
Adult ; Aged ; Anticoagulants/adverse effects ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; China/epidemiology ; Female ; Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; SARS-CoV-2/drug effects ; SARS-CoV-2/isolation & purification ; Venous Thromboembolism/drug therapy ; Venous Thromboembolism/etiology
Czasopismo naukowe
Tytuł :
An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug.
Autorzy :
D'Elia E; Cardiovascular Department, Hospital Papa Giovanni XXIII, Piazza OMS 1, Bergamo, Italy. .
Gori M; Cardiovascular Department, Hospital Papa Giovanni XXIII, Piazza OMS 1, Bergamo, Italy.
Grosu A; Cardiovascular Department, Hospital Papa Giovanni XXIII, Piazza OMS 1, Bergamo, Italy.
Iorio A; Cardiovascular Department, Hospital Papa Giovanni XXIII, Piazza OMS 1, Bergamo, Italy.
Lorini FL; Cardiovascular Department, Hospital Papa Giovanni XXIII, Piazza OMS 1, Bergamo, Italy.
Falanga A; Cardiovascular Department, Hospital Papa Giovanni XXIII, Piazza OMS 1, Bergamo, Italy.; Department of Medicine and Surgery, University of Milan, Milan, Italy.
Di Marco F; Cardiovascular Department, Hospital Papa Giovanni XXIII, Piazza OMS 1, Bergamo, Italy.; Department of Health Sciences, University of Milan, Milan, Italy.
Senni M; Cardiovascular Department, Hospital Papa Giovanni XXIII, Piazza OMS 1, Bergamo, Italy.
Pokaż więcej
Źródło :
BMC pulmonary medicine [BMC Pulm Med] 2021 Mar 24; Vol. 21 (1), pp. 102. Date of Electronic Publication: 2021 Mar 24.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Anticoagulants/*administration & dosage
COVID-19/*complications
Dabigatran/*administration & dosage
Heparin/*administration & dosage
Pulmonary Embolism/*prevention & control
Pulmonary Embolism/*virology
Warfarin/*administration & dosage
Administration, Oral ; Anticoagulants/therapeutic use ; Dabigatran/therapeutic use ; Drug Therapy, Combination ; Heparin/therapeutic use ; Humans ; Male ; Middle Aged ; Pulmonary Embolism/drug therapy ; Recurrence ; Warfarin/therapeutic use
Czasopismo naukowe
Tytuł :
Association of adipocytokines serum levels with left atrial thrombus formation in atrial fibrillation patients on oral anticoagulation (Alert) - A cross-sectional study.
Autorzy :
Blessberger H; Johannes Kepler University Linz, Medical Faculty, Linz, Austria; Department of Cardiology, Kepler University Hospital, Linz, Austria. Electronic address: .
Mueller P; Department of Cardiology, Pneumology and Angiology, University Hospital Duesseldorf, Germany; Department of Cardiology II - Electrophysiology, University Hospital of Muenster, Germany.
Makimoto H; Department of Cardiology, Pneumology and Angiology, University Hospital Duesseldorf, Germany.
Hauffe F; Department of Cardiology, Pneumology and Angiology, University Hospital Duesseldorf, Germany.
Meissner A; Department of Cardiology, Pneumology and Angiology, University Hospital Duesseldorf, Germany.
Gemein C; Department of Cardiology, University Hospital Giessen, Germany; Clinic for Cardiology, Klinikum Frankfurt Hoechst, Frankfurt, Germany.
Schmitt J; Department of Cardiology, University Hospital Giessen, Germany.
Hamm C; Department of Cardiology, University Hospital Giessen, Germany.
Deneke T; Department of Cardiology, Heart Center (Herz- und Gefäßklinik GmbH), Bad Neustadt a.d. Saale, Germany.
Schiedat F; Department of Cardiology, BG University Hospital Bergmannsheil, Bochum, Germany.
Mügge A; Department of Cardiology, BG University Hospital Bergmannsheil, Bochum, Germany.
Gabriel M; Johannes Kepler University Linz, Medical Faculty, Linz, Austria; Institute of Nuclear Medicine and Endocrinology, Kepler University Hospital, Linz, Austria.
Steinwender C; Johannes Kepler University Linz, Medical Faculty, Linz, Austria; Department of Cardiology, Kepler University Hospital, Linz, Austria; Department of Internal Medicine II, Paracelsus Medical University Salzburg, Austria.
Pokaż więcej
Źródło :
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2021 Mar 10; Vol. 31 (3), pp. 860-868. Date of Electronic Publication: 2020 Nov 12.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Adipokines/*blood
Anticoagulants/*administration & dosage
Atrial Fibrillation/*drug therapy
Stroke/*prevention & control
Thromboembolism/*prevention & control
Thrombosis/*prevention & control
Adiponectin/blood ; Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; Atrial Fibrillation/blood ; Atrial Fibrillation/diagnostic imaging ; Biomarkers/blood ; Body Mass Index ; Cross-Sectional Studies ; Cytokines/blood ; Echocardiography, Transesophageal ; Female ; Germany ; Humans ; Leptin/blood ; Male ; Middle Aged ; Nicotinamide Phosphoribosyltransferase/blood ; Prospective Studies ; Resistin/blood ; Risk Assessment ; Risk Factors ; Stroke/blood ; Stroke/diagnosis ; Thromboembolism/blood ; Thromboembolism/diagnosis ; Thrombosis/blood ; Thrombosis/diagnostic imaging ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis - Reply to Jacobs & Ryan comment.
Autorzy :
Speed V; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK.
Roberts LN; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital NHS Foundation Trust, London, UK.
Arya R; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital NHS Foundation Trust, London, UK.
Patel JP; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Mar; Vol. 19 (3), pp. 872-873.
Typ publikacji :
Letter; Comment
MeSH Terms :
Anticoagulants*
Rivaroxaban*/adverse effects
Body Weight ; Humans ; Thiophenes
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies